Zobrazeno 1 - 10
of 37
pro vyhledávání: '"David C. Rice"'
Autor:
John V. Heymach, Barbara Mino, J. Jack Lee, Pedro Rocha, Cesar A. Moran, David C. Rice, Edwin R. Parra, Humam Kadara, Boris Sepesi, Lei Feng, Luisa M. Solis, Carmen Behrens, Ignacio I. Wistuba, Don L. Gibbons, Jianjun Zhang, Chad J. Creighton, Jaime Rodriguez-Canales
Publikováno v:
Clinical Lung Cancer. 22:e415-e424
Introduction Immune infiltration in lung adenocarcinomas (LUADs) has been associated with response to immune checkpoint inhibitors. Clinical features underlying differential responses of patients with LUADs to immunotherapy are not well understood. H
Autor:
Cheuk Hong Leung, Wayne L. Hofstetter, John V. Heymach, Alexandre Reuben, Myrna C.B. Godoy, Ara A. Vaporciyan, Padmanee Sharma, Yasir Elamin, Neda Kalhor, Robert R. Jenq, Junya Fujimoto, Tina Cascone, Anne S. Tsao, William N. William, Charles Lu, Frank E. Mott, Nadim J. Ajami, Don L. Gibbons, Jack A. Roth, David C. Rice, Luisa M. Solis, Hai T. Tran, Brett W. Carter, Lauren Averett Byers, Andrew Futreal, Lorenzo Federico, Annikka Weissferdt, Garrett L. Walsh, Reza J. Mehran, Chantale Bernatchez, George R. Blumenschein, Jennifer A. Wargo, Heather Lin, Cara Haymaker, Xiuning Le, Jonathan M. Kurie, Mehmet Altan, James P. Allison, Stephen G. Swisher, Edwin R. Parra, Boris Sepesi, Hitoshi Dejima, Frank V. Fossella, Jianjun Zhang, Bonnie S. Glisson, Mara B. Antonoff, Abdul Wadud Khan, Apar Pataer, Alejandro Francisco-Cruz, Ignacio I. Wistuba, Humam Kadara, J. Jack Lee, Ferdinandos Skoulidis
Publikováno v:
Nat Med
Ipilimumab improves clinical outcomes when combined with nivolumab in metastatic non-small cell lung cancer (NSCLC), but its efficacy and impact on the immune microenvironment in operable NSCLC remain unclear. We report the results of the phase 2 ran
Autor:
John V. Heymach, David C. Rice, Neda Kalhor, William N. William, Frank V. Fossella, Don L. Gibbons, Annikka Weissferdt, Vincent K. Lam, Stephen G. Swisher, Ara A. Vaporciyan, Frank E. Mott, Heather Lin, Boris Sepesi, J. Jack Lee, Ignacio I. Wistuba, Edwin R. Parra, Reza J. Mehran, Carmen Behrens, Anne S. Tsao, Mei Jiang, Jianjun Zhang, Tina Cascone, Cesar A. Moran, Charles Lu, Myrna C.B. Godoy, George R. Simon, Mara B. Antonoff
Publikováno v:
Clinical Cancer Research. 26:3525-3536
Purpose: Nintedanib enhances the activity of chemotherapy in metastatic non–small cell lung cancer (NSCLC). In this phase I/II study, we assessed safety and efficacy of nintedanib plus neoadjuvant chemotherapy, using major pathologic response (MPR)
Autor:
Tina Cascone, Ting Xu, Quynh Nhu Nguyen, David C. Rice, Jack A. Roth, Saumil Gandhi, Wayne L. Hofstetter, Zhongxing Liao, Arlene M. Correa, Mara B. Antonoff, Anne S. Tsao, Ara A. Vaporciyan, Reza J. Mehran, Ravi Rajaram, Stephen G. Swisher, Boris Sepesi, Vassiliki A. Papadimitrakopoulou, Garrett L. Walsh
Publikováno v:
Clinical Lung Cancer. 21:e294-e301
Introduction The standard of care for stage IIIA (N2) non–small-cell lung cancer (NSCLC) includes concurrent definitive chemoradiation (dCRT) followed by durvalumab, thus challenging the role of surgery in resectable patients. We assessed locoregio
Autor:
Eric L. Brown, Garrett L. Walsh, Reza J. Mehran, Luis G LeonNovelo, Jack A. Roth, Jitesh B. Shewale, Arlene M. Correa, Ara A. Vaporciyan, Wayne L. Hofstetter, Boris Sepesi, Erin M. Corsini, Mara B. Antonoff, Stephen G. Swisher, David C. Rice, Alan G. Nyitray
Publikováno v:
Journal of Surgical Oncology. 122:495-505
Background The improvement in the management of lung cancer have the potential to improve survival in patients undergoing resection for early-stage (stage I and II) non-small cell lung cancer (NSCLC), but few studies have evaluated time trends and id
Autor:
Alex A. Adjei, David H. Harpole, Ritu R. Gill, Charles B. Simone, Ellen Yorke, Andreas Rimner, Anne S. Tsao, B.C. John Cho, Andrew A. Jackson, Valerie W. Rusch, Harvey I. Pass, Marc de Perrot, Daniel R. Gomez, Fred R. Hirsch, Raphael Bueno, Mary Hesdorffer, David C. Rice, Kenneth E. Rosenzweig
Publikováno v:
Journal of Thoracic Oncology. 14:1172-1183
Introduction Detailed guidelines regarding the use of radiation therapy for malignant pleural mesothelioma (MPM) are currently lacking because of the rarity of the disease, the wide spectrum of clinical presentations, and the paucity of high-level da
Autor:
Annikka Weissferdt, Yasir Elamin, John V. Heymach, Erin M. Corsini, Mara B. Antonoff, Frank E. Mott, Reza J. Mehran, Garret Walsh, Anne Tsao, Wayne L. Hofstetter, Mehmet Altan, Tina Cascone, Charles Lu, Ferdinandos Skoulidis, Frank V. Fossella, Jack A. Roth, Boris Sepesi, Jianjun Zhang, Cheuk Hong Leung, George R. Blumenschein, Stephen G. Swisher, Heather Lin, Apar Pataer, Xiuning Le, Jonathan M. Kurie, David C. Rice, Don L. Gibbons, Bonnie S. Glisson, Ara A. Vaporciyan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Tumor and nodal downstaging following neoadjuvant therapy in resectable non-small cell lung cancer (NSCLC) are important markers of therapeutic response associated with favorable prognosis. We studied the impact of four different systemic
Autor:
Mara B. Antonoff, Jianjun Zhang, Jing Wang, Alexandre Reuben, Kyle G. Mitchell, Don L. Gibbons, Wayne L. Hofstetter, Garrett L. Walsh, Tina Cascone, Reza J. Mehran, Boris Sepesi, Hai T. Tran, Mayra E. Vasquez, Jack A. Roth, Chantale Bernatchez, Erin M. Corsini, Ara A. Vaporciyan, Cara Haymaker, Stephen G. Swisher, John V. Heymach, Qi Wang, David C. Rice
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 146
Objectives The influence of surgical approach on systemic inflammatory response and the subsequent oncologic impact for non-small cell lung cancer is debated. We aimed to measure the effects of thoracic surgical approach on peripheral cytokine milieu
Autor:
Erin M. Corsini, Annikka Weissferdt, Wayne L. Hofstetter, Ara A. Vaporciyan, Garrett L. Walsh, David C. Rice, John V. Heymach, Boris Sepesi, Nicolas Zhou, Tina Cascone, Stephen G. Swisher, Jack A. Roth, Apar Pataer, Reza J. Mehran, Ravi Rajaram, Mara B. Antonoff
Publikováno v:
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 59(1)
OBJECTIVES Major pathological response (MPR) is prognostic of outcomes for patients with non-small-cell lung cancer following neoadjuvant chemotherapy and is used as the primary end point in neoadjuvant immunotherapy trials. We studied the influence
Autor:
António Campos, Se Jin Jang, Semir Vranic, Domenico Coppola, Liliana Dalurzo, Dominic V. Spagnolo, David C. Rice, Giovanni Falconieri, Lilian Edmunds, Fernando Cunha, Ana Catarino, Stefano Pizzolitto, Alessandro De Pellegrin, Faruk Skenderi, Ming Lian Oon, Jae Y. Ro, Reza J. Mehran, Fredrik Petersson, Cesar A. Moran, Gerald Langman, Siaw Ming Chai, Arlene M. Correa, Hans Brunnström, Filomena Medeiros, Fernando Augusto Soares, Andrew Laycock, Sergio Pina-Oviedo, Göran Elmberger, Irene Sansano Valero, Boris Sepesi, Kaleigh E. Lindholm, Santiago Ramón y Cajal, Garrett L. Walsh, Jose R. Torrealba
We present 783 surgical resections of typical and atypical carcinoid tumors of the lung identified in the pathology files of 20 different pathology departments. All cases were critically reviewed for clinical and pathological features and further cor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dc29b6d533be6784be5bec6514537a2
https://hdl.handle.net/10576/13272
https://hdl.handle.net/10576/13272